ENGN Earnings

Quarterly EPS
$-0.32
Q3 2024
$-0.35
Q4 2024
$-0.48
Q1 2025
$-0.51
Q2 2025
$-0.57
Q3 2025
$-0.74
Q4 2025
$-0.44
Q1 2026
$-0.43
Q2 2026
Latest RevenueN/A
Latest Net Income-30227000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.430-30227000+15.7%
Q1 2026-$0.440-29752000+8.3%
Q4 2025-$0.740-37880000-111.4%
Q3 2025-$0.570-28991000-78.1%
Q2 2025-$0.510-25815000-34.2%
Q1 2025-$0.480-24616000-4.3%
Q4 2024-$0.350-15299000
Q3 2024-$0.320-14148000
Q2 2024-$0.380-14984000
Q1 2024-$0.460-10711000
enGene Therapeutics (ENGN) — Earnings